Sandimmune® (cyclosporine capsules, USP) 100 mg soft gelatin capsules and Neoral® (cyclosporine capsules, USP) MODIFIED 100 mg soft gelatin capsules prescription drug blister packages
Published March 18, 2020
Summary
CPSC records recall 20091, published March 18, 2020. Reported units: About 73,000.
What's the hazard
The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act (PPPA), posing a risk of poisoning if the contents are swallowed by young children.
What to do
Consumers should immediately secure the product out of the sight and reach of children and contact the firm to request a free child-resistant pouch in which to store the blister package medications. Consumers can continue to use the medication as directed. The child-resistant pouches should be used to store these medications until new child-resistant blister packaging is available.
Get an email when a new CPSC recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Distributor
- Novartis Pharmaceuticals Corporation, of East Hanover, N.J.
- Country
- US
Related recalls
- CPSCSoap Supply Co. Lye, Soap Makers Lye, California Soap Supply, Combo Pure Solutions, Red Crown High Test Lye,March 18, 2020
- CPSCSodium Hydroxide, Lye/Caustic Soda and Potassium Hydroxide, Caustic Potash AshMarch 18, 2020
- CPSC100% Sodium Hydroxide Drain CleanerMarch 18, 2020
- CPSCHonda EB2200i, EU2200i, EU2200i Companion and EU2200i Camo Portable GeneratorsMarch 17, 2020
- CPSCFinch three-drawer dressersMarch 12, 2020
- CPSCLine 6 Relay G10 Digital Wireless Guitar Systems and USB Charging CablesMarch 12, 2020
Questions about this recall
Was Sandimmune® (cyclosporine capsules, USP) 100 mg soft gelatin capsules and Neoral® (cyclosporine capsules, USP) MODIFIED 100 mg soft gelatin capsules prescription drug blister packages recalled?
Yes. CPSC published recall 20091 on March 18, 2020. Reported hazard: The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act (PPPA), posing a risk of poisoning if the contents are swallowed by young children.
What should I do if I have this product?
Consumers should immediately secure the product out of the sight and reach of children and contact the firm to request a free child-resistant pouch in which to store the blister package medications. Consumers can continue to use the medication as directed. The child-resistant pouches should be used to store these medications until new child-resistant blister packaging is available.